What is Compugen's share price today?
Compugen (CGEN) share price today is $2.02 as of November 5, 2026 at 12:22 AM IST. The stock touched a day high of $2.04 and a day low of $1.98.What exchange does Compugen stock trade on, and under what ticker symbol?
Compugen stock trades on NASDAQ under the ticker symbol CGEN.What is Compugen's market capitalization?
Compugen's market capitalization is $187.55M as of November 5, 2026 at 12:22 AM IST.What is Compugen's price-to-earnings (P/E) ratio?
Compugen's price-to-earnings (P/E) ratio is 5.21 as of November 4, 2026.What is Compugen's price-to-book (P/B) ratio?
Compugen's price-to-book (P/B) ratio is 2.11 as of November 4, 2026.Can Indian investors buy Compugen shares?
Yes, You can buy Compugen shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Compugen shares from India?
Indian investors can buy Compugen shares in three steps: 1. Search Compugen on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Compugen shares for Indian investors?
Since Compugen trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Compugen shares via Tickertape?
Indian investors can start investing in Compugen (CGEN) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 4.9382 shares at the current price of $2.02.
$
₹
$2.020.74% (+0.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
5.21
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
2.11
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$0.38
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
1.28
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
47.56%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 5 analysts reports
Buy5 analysts
Hold0 analyst
Sell0 analyst
Price Upside
+132.32%
Earnings Growth
-189.19%
Rev. Growth
-87.3%
Company Profile
Company Profile
P/E Ratio
36.00
36.00
1Y Return
23.62%
23.62%
Buy Reco %
85.18
85.18
P/E Ratio
34.46
34.46
1Y Return
18.86%
18.86%
Buy Reco %
68.18
68.18
P/E Ratio
113.80
113.80
1Y Return
33.07%
33.07%
Buy Reco %
78.26
78.26
P/E Ratio
31.29
31.29
1Y Return
22.77%
22.77%
Buy Reco %
90.00
90.00
ILMN
P/E Ratio
38.99
38.99
1Y Return
98.52%
98.52%
Buy Reco %
47.61
47.61
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$1.98Baseline
Analyst Target - 1 year
Target$4.6+132.32%
All values in $
2026
Current$1.98Baseline
Analyst Target - 1 year
Target$4.6+132.32%
All values in $
Revenue Forecast
Revenue Forecast
Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.
The next fiscal year's mean estimate implies -87.30% growth, versus a trailing 3-year CAGR of 113.28%.
2025
Current$72.76Baseline
Forecast for Dec 2026
High$17.57-75.84%
Average$9.23-87.3%
Low$4.77-93.43%
All values in $ Million
2025
Current$72.76Baseline
Forecast for Dec 2026
High$17.57-75.84%
Average$9.23-87.3%
Low$4.77-93.43%
All values in $ Million
Earnings Per Share Forecast
Earnings Per Share Forecast
2025
Current$0.37Baseline
Forecast for Dec 2026
High$-0.3-181.08%
Average$-0.33-189.19%
Low$-0.35-194.59%
All values in $
2025
Current$0.37Baseline
Forecast for Dec 2026
High$-0.3-181.08%
Average$-0.33-189.19%
Low$-0.35-194.59%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.55 | 6.70 | 17.13 | 1.47 | 2.28 | 1.25 | 1.89 | 67.33 | 2.17 | 2.60 |
Gross Profit | 0.45 | 5.15 | 13.53 | 0.79 | -0.11 | -0.40 | 0.24 | 63.79 | 0.35 | -0.09 |
| Net Income | -7.26 | -2.12 | 1.27 | -6.11 | -7.18 | -7.34 | -6.97 | 56.84 | -7.66 | -7 |
| Net Profit Margin | -283.97% | -31.67% | 7.44% | -415.83% | -314.40% | -584.08% | -369.06% | 84.42% | -352.43% | -269.25% |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareBiotechnology
HealthcareBiotechnology
Valuation
Returns
Forecast
Compare valuation on Screener| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Compugen | 5.21 | 2.11 | 1.28 |
| Thermo Fisher Scientific Inc | 36.00 | 4.71 | 2.03 |
| Agilent Technologies Inc | 34.46 | 6.69 | 1.48 |
Price Comparison
Price Comparison
Compare CGEN with any stock or ETFCompare CGEN with any stock or ETF
Comparing from
CGEN
TMO
A
The 12-month consensus target implies 132.32% growth, versus a trailing 3-year CAGR of 38.69%.